Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2Breast 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Breast Neoplasms 1316Triple Negative Breast Neoplasms 233Ovarian Neoplasms 115Carcinoma, Non-Small-Cell Lung 89Colorectal Neoplasms 86Neoplasm Metastasis 83Prostatic Neoplasms 79Neoplasms 76Lung Neoplasms 70Melanoma 57Pancreatic Neoplasms 54Endometrial Neoplasms 54Stomach Neoplasms 49Uterine Cervical Neoplasms 44Carcinoma, Intraductal, Noninfiltrating 41Squamous Cell Carcinoma of Head and Neck 38Colonic Neoplasms 37Head and Neck Neoplasms 33Carcinoma, Renal Cell 33Esophageal Neoplasms 27Breast Carcinoma In Situ 27Small Cell Lung Carcinoma 25Sarcoma 25Brain Neoplasms 25Urinary Bladder Neoplasms 22Anatomic Stage I Breast Cancer AJCC v8 22Carcinoma, Transitional Cell 20Advanced Breast Cancer 18Liver Neoplasms 17Gastrointestinal Neoplasms 17

Interventions

trastuzumab deruxtecan 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Breast × 90 days × Clear all
NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Recruiting
70 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT07524829 2026-04-13

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

Azienda Sanitaria Locale di Asti

Phase NA Recruiting
124 enrolled
Breast

Treatment Adherence and Compliance, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡